2005
DOI: 10.1007/bf03345531
|View full text |Cite
|
Sign up to set email alerts
|

Adrenocortical carcinoma producing 11-deoxycorticosterone: A rare cause of mineralocorticoid hypertension

Abstract: A 37-yr-old man presented with the classic signs of mineralocorticoid excess hypertension and hypokalemia. The cause was not aldosterone excess, but elevation of plasma 11-deoxycorticosterone (DOC). Computed tomography (CT) scans showed a large right adrenal mass without signs of metastatic disease. The tumor was removed by open laparotomy, and histology revealed an adrenocortical carcinoma. Two yr after diagnosis, the patient is in good general condition and there is no sign of recurrence or metastatic diseas… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2006
2006
2019
2019

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 37 publications
(5 citation statements)
references
References 17 publications
0
5
0
Order By: Relevance
“…An uncommon diagnosis of mineralocorticoid excess has been reported recently by Mussig et al [9] in a man with Conn syndrome and isolated plasma 11-deoxycorticosterone (DOC) excess. Only 11 cases have been reported in the literature, making this isolated malignancy extremely rare.…”
Section: Biochemical Functionmentioning
confidence: 92%
See 1 more Smart Citation
“…An uncommon diagnosis of mineralocorticoid excess has been reported recently by Mussig et al [9] in a man with Conn syndrome and isolated plasma 11-deoxycorticosterone (DOC) excess. Only 11 cases have been reported in the literature, making this isolated malignancy extremely rare.…”
Section: Biochemical Functionmentioning
confidence: 92%
“…Only 11 cases have been reported in the literature, making this isolated malignancy extremely rare. Combined mineralocorticoid and glucocorticoid secretion has also been reported in ACC, emphasizing the need for hormonal screening in patients with adrenal masses [9].…”
Section: Biochemical Functionmentioning
confidence: 99%
“…Although mice with constitutive adrenocortical β-catenin activation develop aldosterone-producing tumors at 10 months of age, the plasma aldosterone concentration decreases with malignant progression, which in some cases is associated with an increase of plasma corticosterone concentration [44]. This is similar to rare human cases, in which patients with APA have later developed hypercortisolism [45][46][47]. Moreover, in cell culture, β-catenin knockdown induces a decrease of cortisol secretion in cell medium due to a preferential DHEA production [41].…”
Section: Review β-Catenin Regulates Hormone Secretion ▼mentioning
confidence: 97%
“…Autonomous aldosterone secretion (which classically leads to hypertension and hypokalemia) is rare in ACC (85,86). More commonly, mineralocorticoid effects are mediated by high cortisol levels or possibly steroid precursors with mineralocorticoid activity, such as 11-deoxycorticosterone (87,88).…”
Section: Patient Presentation/clinical Characteristicsmentioning
confidence: 99%